PrescriptionGiant is a FREE prescription savings program that can save you up to 75% on your prescriptions with or without insurance!

Oncaspar (Generic Pegaspargase Injection)

Actual product appearance may differ slightly.

Click the CARD below to print or take a screenshot on your mobile phone or tablet. There is no need to download another app!


If you would like to personalize your card enter your full name in the member name field below the card at this link and click the Update button.

Why is this medication prescribed?

Oncaspar is a prescription medication used in the treatment of acute lymphoblastic leukemia (ALL), a type of cancer that affects the white blood cells. It is specifically used in patients with ALL who have developed an allergic reaction or intolerance to the chemotherapy medication called asparaginase, which is a standard component of ALL treatment.

Asparaginase is an enzyme that helps in preventing the growth of cancer cells by depleting the levels of asparagine, an essential amino acid for their survival. However, some individuals may develop hypersensitivity or allergic reactions to the native form of asparaginase derived from E. coli bacteria. In such cases, Oncaspar (pegaspargase), a modified form of asparaginase, is prescribed as an alternative.

Oncaspar works in a similar way to native asparaginase by depleting asparagine levels, thus hindering the growth of cancer cells. However, its modified structure reduces the likelihood of allergic reactions compared to the native form.

How should this medicine be used?

Oncaspar (pegaspargase) is a medication used in the treatment of acute lymphoblastic leukemia (ALL), a type of blood cancer. It is typically administered as part of a combination chemotherapy regimen.

The specific dosing and administration schedule for Oncaspar may vary depending on factors such as the patient’s age, weight, overall health, and the specific treatment protocol being followed. It is important to follow the instructions provided by the prescribing healthcare professional or the medical team.

Oncaspar is given by injection into a vein (intravenous infusion) or as an intramuscular injection. The infusion is usually administered in a healthcare setting, such as a hospital or clinic, under the supervision of a medical professional. The injection site should be rotated to reduce the risk of local irritation or reactions.

It is crucial to adhere to the prescribed treatment schedule and not miss any doses. If a dose is missed, it is important to contact the healthcare provider for guidance on how to proceed.

It’s important to note that this information is a general overview and not a substitute for specific instructions from a healthcare professional. Always consult your doctor or healthcare provider for personalized advice regarding the appropriate use of Oncaspar or any other medication.

Other uses for this medicine

Oncaspar (pegaspargase) is primarily used for the treatment of acute lymphoblastic leukemia (ALL) in patients who have developed an allergic reaction or intolerance to the standard asparaginase therapy. However, it may also be used off-label in some cases for the treatment of other conditions or in combination with other medications as determined by a healthcare professional. Off-label use refers to the use of a medication for a purpose other than what it is officially approved for by regulatory authorities.

What special precautions should I follow?

Regarding special precautions, it’s important to consider the following:

  • Allergy or hypersensitivity: Individuals who have a known allergy to pegaspargase or any of its components should not use Oncaspar. It’s crucial to inform your healthcare provider about any known allergies or hypersensitivity reactions to medications.
  • Pancreatitis: Oncaspar treatment has been associated with an increased risk of pancreatitis (inflammation of the pancreas). Patients should be closely monitored for signs and symptoms of pancreatitis, such as abdominal pain, nausea, vomiting, and changes in blood glucose levels. If pancreatitis is suspected, treatment may need to be discontinued.
  • Bleeding disorders: Oncaspar may affect blood clotting factors, potentially increasing the risk of bleeding. Individuals with a history of bleeding disorders or those taking medications that affect blood clotting should be closely monitored.
  • Liver and kidney function: Oncaspar can affect liver and kidney function. Regular monitoring of liver enzymes, bilirubin, and renal function is necessary during treatment. Dose adjustments may be required for patients with impaired liver or kidney function.
  • Other medications and therapies: Inform your healthcare provider about all medications, supplements, or herbal products you are taking, as they may interact with Oncaspar. Certain medications or therapies may affect the effectiveness or increase the side effects of Oncaspar.
  • Pregnancy and breastfeeding: The use of Oncaspar during pregnancy or breastfeeding should be discussed with a healthcare provider. It is important to weigh the potential benefits against the potential risks for both the mother and the baby.

These precautions are not exhaustive, and it’s essential to consult with a healthcare professional for comprehensive information and guidance specific to your individual circumstances.

What special dietary instructions should I follow?

There are no specific dietary instructions associated with Oncaspar (pegaspargase) treatment. However, it’s generally recommended to follow a balanced and healthy diet to support overall well-being during cancer treatment. Your healthcare provider or a registered dietitian can provide personalized dietary recommendations based on your specific needs and treatment plan.

What should I do if I forget a dose?

If you forget a dose of Oncaspar, it’s important to contact your healthcare provider or the medical team overseeing your treatment. They will provide guidance on the appropriate course of action based on the specific circumstances. It may involve rescheduling the missed dose or adjusting the treatment schedule. It is generally not advisable to double the dose to make up for a missed one without consulting a healthcare professional, as it can increase the risk of side effects or complications.

What side effects can this medication cause?

Oncaspar (pegaspargase) can cause several side effects, which can vary in severity and individual susceptibility. Not all individuals will experience these side effects, and some may experience them to different degrees. It’s important to note that the benefits of the medication usually outweigh the potential risks of side effects. Common side effects of Oncaspar may include:

  • Allergic reactions: While Oncaspar is a modified form of asparaginase intended to reduce allergic reactions, some individuals may still experience allergic responses. Signs of an allergic reaction may include rash, itching, swelling, dizziness, difficulty breathing, or tightness in the chest. If any of these symptoms occur, immediate medical attention should be sought.
  • Pancreatitis: In some cases, Oncaspar treatment may lead to pancreatitis, which is inflammation of the pancreas. Symptoms can include severe abdominal pain, nausea, vomiting, and changes in blood glucose levels. If you experience these symptoms, you should notify your healthcare provider promptly.
  • Coagulation disorders: Oncaspar can affect blood clotting factors, which may increase the risk of bleeding or bruising. Inform your healthcare provider if you notice any unusual bleeding, such as nosebleeds, bleeding gums, or blood in the urine or stool.
  • Liver and kidney problems: Oncaspar may cause liver or kidney abnormalities, as indicated by changes in liver function tests or renal function tests. Monitoring of liver enzymes and kidney function is usually performed during treatment.
  • Fatigue: Feeling tired or fatigued is a common side effect of many cancer treatments, including Oncaspar. It is important to get adequate rest and consult with your healthcare provider if fatigue becomes persistent or severely impacts your daily functioning.
  • Gastrointestinal issues: Nausea, vomiting, diarrhea, or constipation may occur. It is important to stay well-hydrated and maintain a balanced diet during treatment. Your healthcare provider may prescribe medications to help manage these symptoms.
  • Decreased appetite: Some individuals may experience a loss of appetite while undergoing Oncaspar treatment. Maintaining proper nutrition and discussing dietary strategies with a healthcare provider or registered dietitian can be helpful in managing this side effect.
  • Changes in blood cell counts: Oncaspar can affect blood cell production, leading to a decrease in white blood cells, red blood cells, or platelets. This may increase the risk of infections, anemia, or bleeding. Regular blood tests are typically conducted to monitor these parameters.

It’s important to promptly report any side effects or concerns to your healthcare provider. They can provide guidance on managing and alleviating these side effects to ensure your treatment course is as comfortable and effective as possible.

What should I know about storage and disposal of this medication?

  • Storage: Oncaspar should be stored in its original packaging at the temperature recommended by the manufacturer or your healthcare provider. Typically, it is stored in a refrigerator between 2°C and 8°C (36°F and 46°F). Do not freeze the medication unless instructed otherwise.
  • Disposal: Proper disposal of Oncaspar should be done in accordance with local regulations for hazardous waste or pharmaceutical waste. It is important to follow local guidelines to prevent any potential harm to the environment or individuals. You can consult your healthcare provider, pharmacist, or local waste disposal authorities for information on proper disposal methods.

In case of emergency/overdose

In case of emergency or overdose, it is crucial to seek immediate medical assistance. Contact your local emergency services or go to the nearest emergency room. It may be helpful to bring the medication packaging or information leaflet along to provide important details to the healthcare professionals.

What other information should I know?

  • Medical information: Keep a list of all medications you are currently taking, including Oncaspar, and share it with your healthcare provider. This includes prescription medications, over-the-counter drugs, herbal supplements, and vitamins. It is important for your healthcare provider to have a complete overview of your medication regimen to avoid potential interactions or complications.
  • Regular monitoring: Oncaspar treatment often requires regular monitoring of blood counts, liver function, kidney function, and other relevant parameters. Attend all scheduled appointments and follow-up visits as advised by your healthcare provider.
  • Emotional support: Cancer treatment can be physically and emotionally challenging. Seek support from your healthcare team, support groups, friends, or family members to help you navigate through the treatment process.
  • Follow instructions: Follow the prescribed treatment plan, including dosing schedule and any additional instructions provided by your healthcare provider. Do not make changes to the medication regimen without consulting your healthcare team.
  • Communication: If you experience any new symptoms, side effects, or concerns during Oncaspar treatment, promptly inform your healthcare provider. Open and honest communication with your healthcare team is vital for effective management and support.

Remember, the information provided here is a general overview and does not substitute personalized medical advice. Always consult your healthcare provider or pharmacist for specific guidance and instructions regarding your Oncaspar treatment.

Copyright © 2023